Frequently Asked Questions

2 The Life is a supplement brand dedicated to providing lab-tested, high-purity compounds for research and personal wellness. All our products undergo rigorous third-party testing and come with Certificates of Analysis to verify purity levels of 99%+.

Yes. Every batch is independently tested by accredited third-party laboratories. We publish the full Certificate of Analysis (CoA) for each product on our Certificate of Analysis page, so you can verify purity, potency, and the absence of contaminants.

Our products are dietary supplements sold for research and educational purposes. They have not been evaluated or approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Always consult a qualified healthcare professional before starting any new supplement regimen.

Yes. We offer a 30-day return policy. If you are not satisfied with your purchase, you may request a refund within 30 days of receiving your order. Please contact our support team for assistance.

Fenbendazole is a broad-spectrum benzimidazole antiparasitic compound originally developed for veterinary use. It belongs to the same chemical family as mebendazole and albendazole, which are approved for human use. In recent years, fenbendazole has gained significant attention in research communities for its potential anticancer properties observed in preclinical studies.

Laboratory studies have shown that fenbendazole may inhibit cancer cell growth through several mechanisms: disrupting microtubule formation, inducing oxidative stress in cancer cells, blocking glucose uptake, and activating the p53 tumor suppressor pathway. Preclinical data suggests potential activity against lung, breast (particularly triple-negative), cervical, and liver cancers. However, no randomized clinical trials in humans have been completed, so these findings remain preliminary.

Commonly reported dosage protocols range from 222 mg to 444 mg per day, often taken on a cyclical schedule such as 3 days on / 4 days off or 5 days on / 2 days off. The cycling approach is designed to support liver health. Dosage may vary based on body weight — our Fenbendazole Dosage Guide provides a detailed breakdown. Always consult a healthcare provider before starting any supplementation protocol.

Fenbendazole is generally considered well-tolerated. The most commonly reported side effects include mild gastrointestinal discomfort (nausea, diarrhea, or abdominal pain), light headache or dizziness, and in rare cases, temporary liver enzyme elevation. This liver enzyme increase is typically reversible with a short break from supplementation. Liver support supplements such as milk thistle (silymarin) are often recommended alongside fenbendazole protocols.

Yes. Fenbendazole is fat-soluble, so taking it with a meal that contains dietary fats significantly improves absorption. Many users take it alongside foods rich in healthy fats such as olive oil, avocado, or fish oil to maximize bioavailability.

The primary difference is the dosage strength per capsule. The 222 mg capsule is typically recommended for individuals under 80 kg or those following a conservative maintenance protocol. The 444 mg capsule is designed for individuals over 80 kg or those following more intensive protocols. Both contain the same 99%+ pure fenbendazole — the only difference is the amount per capsule.

Drug interactions with fenbendazole are not well-documented in clinical literature. While no major interactions have been widely reported, individuals on blood thinners, anti-seizure medications, or undergoing chemotherapy or immunotherapy should consult their healthcare provider before combining fenbendazole with any prescription medications. It is generally recommended to pause fenbendazole 2 days before and after immunotherapy infusions.

Ivermectin is an FDA-approved antiparasitic medication used to treat conditions such as river blindness (onchocerciasis), strongyloidiasis, and scabies. It was discovered in the 1970s and its developers were awarded the Nobel Prize in Medicine in 2015. Beyond its established use as an antiparasitic, ivermectin has attracted research interest for potential anticancer and immunomodulatory properties observed in laboratory studies.

Preclinical research has identified several mechanisms through which ivermectin may affect cancer cells, including inhibition of proliferation, induction of apoptosis (programmed cell death), suppression of angiogenesis, and modulation of the tumor microenvironment — particularly converting immunologically "cold" tumors to "hot" ones that may respond better to immunotherapy. Studies have shown activity against breast, colorectal, melanoma, gastric, and other cancer cell lines in laboratory settings. Clinical trials in humans are still in very early stages.

For its approved antiparasitic uses, ivermectin is typically dosed at 150–200 mcg per kilogram of body weight, taken as a single dose. Research-oriented protocols for other applications vary widely and have not been standardized through clinical trials. Ivermectin should be taken on an empty stomach with water. Always follow the guidance of a qualified healthcare professional.

At standard doses, ivermectin is generally well-tolerated. Potential side effects include nausea, diarrhea, dizziness, and fatigue. In people being treated for parasitic infections, a Mazzotti-type reaction (fever, itching, rash) may occur as parasites die off. Ivermectin may interact with warfarin and other blood thinners. Large doses or prolonged use beyond standard protocols can lead to more serious effects such as confusion, tremors, or coordination problems.

Research suggests ivermectin may modulate the immune system by influencing the tumor microenvironment. Laboratory studies have shown it can promote the conversion of immunologically "cold" tumors (which evade immune detection) into "hot" tumors that are more responsive to the body's immune defenses and immunotherapy treatments. It may also affect PAK1 kinase signaling, which plays a role in immune regulation and cancer cell proliferation. These findings are based on preclinical research and have not yet been confirmed in large-scale human studies.

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protective protein naturally found in human gastric juice. First isolated by researchers in 1993, it has been extensively studied in animal models for its regenerative properties across tendons, ligaments, muscles, nerves, bones, and the gastrointestinal lining.

Based on preclinical research, BPC-157 has been studied for tissue repair and regeneration (tendons, ligaments, muscles), anti-inflammatory support, gut health and gastrointestinal lining protection, joint and mobility support, neuroprotective effects, and promotion of angiogenesis (formation of new blood vessels for tissue repair). It is important to note that human clinical data remains very limited, and most evidence comes from animal studies.

Oral BPC-157 capsule dosages typically range from 200 to 500 mcg taken once or twice daily on an empty stomach. Many protocols suggest 4–8 week cycles followed by a break of several weeks. For gut health specifically, oral capsules may offer particular advantages since the peptide interacts directly with the gastrointestinal tract. Dosage may vary based on body weight, condition severity, and individual response.

Each delivery method has its advantages. Oral capsules are convenient, non-invasive, and may be particularly effective for gut-related applications, as BPC-157 interacts directly with the gastric lining. Injectable BPC-157 (subcutaneous) offers higher bioavailability and may be preferred for targeted musculoskeletal support such as tendon, ligament, or joint recovery. Our BPC-157 Capsules vs. Injections guide provides a detailed comparison.

In the limited human studies and pilot trials conducted, BPC-157 has been reported as generally well-tolerated. Potential side effects include mild nausea, temporary fatigue, headache, and dizziness. Animal toxicity studies have not identified a lethal dose threshold, and no teratogenic, genotoxic, or anaphylactic effects have been observed in preclinical research. However, long-term human safety data remains limited, so caution is advised.

BPC-157 is generally used in cycles rather than continuously. Most protocols recommend 4–8 weeks of use followed by several weeks off. While preclinical studies have not revealed toxicity concerns, long-term human data is insufficient to confirm safety for extended continuous use. Cycling is recommended as a precautionary approach until more research is available.

Currently, we ship within the United States only. We offer free standard shipping on all domestic orders. We are exploring international shipping options and hope to expand to additional countries in the future.

Orders are processed within 1–2 business days. Standard shipping within the United States typically takes 3–7 business days. All orders include tracking information sent to your email once shipped.

We offer a 30-day return policy from the date of delivery. If you are not satisfied with your purchase, contact our support team to initiate a return. Products must be in their original, unopened packaging to qualify for a full refund. Please visit our Contact page to get in touch.

Store all supplements in a cool, dry place away from direct sunlight and moisture. Keep bottles tightly sealed when not in use. Our BPC-157 capsules use the Arginate form, which is stable at room temperature — no refrigeration required. Do not expose any supplements to extreme heat or freezing temperatures.